CD

Charu Dhawan

Active Director Director DIN 01996736
DIN 01996736 First appointment Nov 1993 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 1993
Shareholding value •••• Premium profile

About Charu Dhawan

Data last updated:

Charu Dhawan is a Director at Rubodex Herbal Private Limited (since 1993). The company operates in FMCG. Rubodex Herbal Private Limited reported revenue of ₹1.83 Cr (FY 2025).

DIN 01996736
Primary Designation Director
Industry FMCG
First Appointment 05 Nov 1993
Oldest Company Age 32 yrs
Largest company Rubodex Herbal Private Limited · ₹1.83 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rubodex Herbal Private Limited U74899DL1993PTC055940
Director05 Nov 19931993₹1.83 Cr (FY 2025)Active

Board colleagues of Charu Dhawan

NameDINCompanyDesignation
Rajiv Dhawan05247611Rubodex Herbal Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rubodex Herbal Private Limited
Premium access

Shareholding and investment profile for Charu Dhawan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charu Dhawan

Charu Dhawan currently holds 1 directorship: Rubodex Herbal Private Limited (Director, since 05 Nov 1993, revenue ₹1.83 Cr (FY 2025)).

Charu Dhawan was first appointed on 05 Nov 1993 as Director at Rubodex Herbal Private Limited.

The current boards of Charu Dhawan's companies include Rajiv Dhawan (Rubodex Herbal Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available